XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Assets    
Unrestricted cash and cash equivalents $ 373,468 $ 409,660
Restricted cash and cash equivalents 32,009 96,968
Loans, interest and fees receivable:    
Loans, interest and fees receivable, at fair value 1,405,765 1,026,424
Loans, interest and fees receivable, gross 99,916 470,293
Allowances for uncollectible loans, interest and fees receivable (including $55.1 million associated with variable interest entities at December 31, 2021) (1,612) (57,201)
Deferred revenue (including $8.2 million associated with variable interest entities at December 31, 2021) (15,878) (29,281)
Net loans, interest and fees receivable 1,488,191 1,410,235
Property at cost, net of depreciation 6,819 7,335
Operating lease right-of-use assets 2,592 4,016
Prepaid expenses and other assets 18,558 15,649
Total assets 1,921,637 1,943,863
Liabilities    
Accounts payable and accrued expenses 50,905 42,287
Operating lease liabilities 2,457 4,842
Notes Payable, net held by VIEs 1,268,821 1,278,864
Senior notes, net 143,310 142,951
Income tax liability 43,100 47,770
Total liabilities 1,508,593 1,516,714
Commitments and contingencies (Note 10)
Shareholders' Equity    
Common stock, no par value, 150,000,000 shares authorized: 14,912,895 and 14,804,408 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively 0 0
Paid-in capital 160,242 227,763
Retained earnings 113,828 60,236
Total shareholders’ equity 274,070 287,999
Noncontrolling interests (751) (500)
Total equity 273,319 287,499
Total liabilities, preferred stock and equity 1,921,637 1,943,863
Series A Preferred Stock [Member]    
Liabilities    
Preferred stock [1] 40,000 40,000
Preferred stock [1] 40,000 40,000
Series B Preferred Stock [Member]    
Liabilities    
Preferred stock 99,725 99,650
Preferred stock 99,725 99,650
Shareholders' Equity    
Series B preferred stock, no par value, 3,188,533 shares issued and outstanding at March 31, 2022 (liquidation preference - $79.7 million); 3,188,533 shares issued and outstanding at December 31, 2021 (1) [1] $ 0 $ 0
[1] Both the Series A preferred stock and the Series B preferred stock have no par value and are part of the same aggregate 10,000,000 shares authorized.